Diffusion- and T2-weighted MR Imaging of the Liver: Effect of Intravenous Administration of Gadoxetic Acid Disodium

DOI Web Site PubMed 被引用文献3件 参考文献30件 オープンアクセス

書誌事項

タイトル別名
  • Diffusion- and T<sub>2</sub>-weighted MR Imaging of the Liver: Effect of Intravenous Administration of Gadoxetic Acid Disodium
公開日
2012
資源種別
journal article
DOI
  • 10.2463/mrms.11.185
公開者
日本磁気共鳴医学会

この論文をさがす

説明

Purpose: We evaluated the effect of intravenous administration of gadoxetic acid disodium to hepatic lesions and liver parenchyma on T2-weighted (T2WI) and diffusion-weighted imaging (DWI).<br> Materials and Methods: One hundred and one consecutive patients with 259 hepatic lesions underwent T2WI and DWI (b-values of 500 and 1000 s/mm2) before and after gadoxetic acid administration. We compared the ratio of signal intensity (SIR) of the liver parenchyma and hepatic lesions, the ratio of contrast intensity of the lesion to the liver (CIR), the apparent diffusion coefficients (ADCs) of the liver and lesions, and lesion detectability between pre- and post-contrast images.<br> Results: SIRs, CIRs, and ADC of focal hepatic lesions were comparable on pre- and post-contrast images, and lesion detectability did not differ significantly between pre- and post-contrast T2WI and DWI. The SIRs of the liver parenchyma were significantly lower on post-contrast DWI (1.4±0.68 [b=500 s/mm2] and 1.71±0.67 [b=1000 s/mm2]) than pre-contrast images (1.89±0.68 [b=500 s/mm2] and 2.26±0.78 [b=1000 s/mm2]) (P<0.001). ADCs of the liver parenchyma were also significantly decreased on post-contrast DWI (0.77±0.32 mm2/s) than pre-contrast images (0.64±0.33 mm2/s) (P=0.001).<br> Conclusion: T2WI and DWI after administration of gadoxetic acid are feasible and do not compromise the SIR, CIR, and ADC of focal hepatic lesions. However, the signal intensity of DWI and ADC value of the liver parenchyma were decreased on gadoxetic acid-enhanced hepatocyte phase images.<br>

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (30)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ